Gastroenterology

Incarceration history and current opioid agonist treatment was associated with antibody testing.

Healthcare provider knowledge on fecal microbiota transplantation as a treatment for inflammatory bowel disease is still lacking.

Only 1 patient died due to HCV-related complications following liver transplantation.

RT001 and RT176 were the most prevalent C difficile ribotypes found from C difficile isolates using PCR testing.

Patients with pediatric solid tumors and hematological malignancies were more prone to C difficile infections.

The accuracy of transient elastography following a sustained virologic response was considered poor.

FMT treatment was less effective for primary C difficile infections.

The FODMAP diet is considered a preferable option for patients with irritable bowel syndrome.

The machine learning model outperformed a comparison logistic regression model in identifying high-risk patients for HBV.

Most of Europe lacks an active and coordinated surveillance plan in place for monitoring hospital-acquired CDI.

Hospitals that use the 3-dose vaccine would spend approximately 37% more on prophylaxis for hepatitis B.

The evidence regarding patients with entecavir-treated chronic hepatitis B without maintaining virological response is limited and uncertain.

CDI rates remained down in 2020 despite an increase in antibiotic use during the pandemic.

Co-infections of HBV and HIV often lead to an increased risk of overall mortality.

Dr. Amar Deshpande said more safety studies are needed before examining whether multiple biologics can be used to treat IBD.

The new assay was 100% on both sensitivity and specificity for detecting C difficile infections from rectal swabs.

Serum concentrations of aminotransferases improved for HCC-DAA and DAA-HCC groups 1 year following surgery.

One lot of the vancomycin kits mistakenly contained a first omeprazole diluent.

Grade 3 injection site redness led to the predefined stopping rules for 10 patients in the clinical trials.

More research is needed on the safety and efficacy of multiple biologics.

IBS is considered 1 of the most expensive conditions in gastroenterology.

Data show patients with chronic IBS had six times the odds of developing glaucoma (OR 6.58; 95% CI, 2.00 - 16.89), in comparison to those without chronic IBS.

Despite conflicting data, investigators form Spain found that gastroesophageal reflux disease and asthma are bidirectional, with each disease exacerbating each other.

CDI patients in the RT 014-020 subgroup had better clinical outcomes.

The Firmicutes/Bacteroidetes ratio was lower for patients with sickle cell disease compared to a healthy control group.